KPC Pharmaceuticals, Inc. (600422.SS)

CNY 16.62

(0.3%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 9.59 Billion 9.43 Billion 8.89 Billion 8.12 Billion 7.43 Billion 6.89 Billion
Total Current Assets 7.03 Billion 6.76 Billion 6.18 Billion 5.56 Billion 4.8 Billion 4.2 Billion
Cash And Short Term Investments 2.09 Billion 1.97 Billion 1.73 Billion 1.8 Billion 1.48 Billion 1.2 Billion
Cash and Cash Equivalents 1.49 Billion 1.65 Billion 1.57 Billion 1.47 Billion 1.27 Billion 1.2 Billion
Short Term Investments 603.79 Million 319.4 Million 160.5 Million 334.75 Million 210.89 Million -15.3 Million
Net Receivables 3.07 Billion 3.06 Billion 2.53 Billion 1.94 Billion 1.82 Billion 1.64 Billion
Inventory 1.68 Billion 1.68 Billion 1.88 Billion 1.71 Billion 1.43 Billion 1.17 Billion
Other Current Assets 167.66 Million 45.87 Million 31.89 Million 97.8 Million 67.9 Million 176.56 Million
Total Non-Current Assets 2.56 Billion 2.66 Billion 2.71 Billion 2.55 Billion 2.63 Billion 2.69 Billion
Net PPE 1.24 Billion 1.29 Billion 1.36 Billion 1.32 Billion 1.35 Billion 1.22 Billion
Good Will And Intangible Assets 617.22 Million 621.72 Million 700.49 Million 662.48 Million 719.36 Million 680.27 Million
Good Will 91.72 Million 91.72 Million 91.72 Million 91.72 Million 91.72 Million 91.72 Million
Intangible Assets 525.49 Million 529.99 Million 608.76 Million 570.75 Million 627.63 Million 588.54 Million
Long-Term Investments 342.18 Million 1.21 Million 117.73 Million -93.21 Million 59.93 Million 589.2 Million
Tax Assets 288.65 Million 245.6 Million 233.83 Million 236.73 Million 211.48 Million 157.63 Million
Other Non Current Assets 63.63 Million 505.62 Million 300.09 Million 424.04 Million 288.76 Million 40.84 Million
Other Assets 1.00 - - - 1.00 -
Total Liabilities 3.9 Billion 4.28 Billion 3.95 Billion 3.51 Billion 3.1 Billion 2.94 Billion
Total Current Liabilities 3.64 Billion 3.88 Billion 3.48 Billion 3.12 Billion 2.77 Billion 2.46 Billion
Account Payables 664.71 Million 977.12 Million 1.23 Billion 823.69 Million 749.35 Million 825.04 Million
Tax Payables 130.07 Million 169.41 Million 187.43 Million 144.04 Million 149.91 Million 182.33 Million
Short Term Debt 1.01 Billion 1.03 Billion 678.02 Million 628 Million 539.83 Million 436.04 Million
Deferred Revenue 90.6 Million 186.37 Million 1.55 Billion 1.66 Billion 1.41 Billion 182.33 Million
Other Current Liabilities 1.86 Billion 1.69 Billion 11.43 Million 10.81 Million 68.59 Million 1.02 Billion
Total Non Current Liabilities 260.99 Million 400.57 Million 467.39 Million 392.72 Million 323.08 Million 474.97 Million
Long-Term Debt 107.56 Million 104.76 Million 149.97 Million 99.7 Million 66.7 Million 254.6 Million
Deferred Revenue Non Current 209.59 Million 207.57 Million 245.33 Million 273.58 Million 227.7 Million 187.44 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -90.5 Million 77.58 Million 56.66 Million 1.04 Million 5.72 Million 4.98 Million
Other Liabilities -0.00 1.00 - 1.00 - 1.00
Total Equity 5.47 Billion 5.14 Billion 4.94 Billion 4.6 Billion 4.33 Billion 3.94 Billion
Stock Holders Equity 5.29 Billion 4.98 Billion 4.78 Billion 4.45 Billion 4.19 Billion 3.82 Billion
Common Stock 757.98 Million 758.25 Million 758.25 Million 758.25 Million 760.94 Million 762.39 Million
Retained Earnings 3.01 Billion 2.71 Billion 2.56 Billion 2.26 Billion 1.99 Billion 1.64 Billion
Accumulated other comprehensive income 401.98 Million 386.96 Million 330.92 Million 298.09 Million 290.99 Million 241.92 Million
Common Stock Equity 5.29 Billion 4.98 Billion 4.78 Billion 4.45 Billion 4.19 Billion 3.82 Billion
Capital Lease Obligation 44.23 Million 44.76 Million 50.47 Million 68.1 Million - -
Total Investments 945.97 Million 320.61 Million 278.23 Million 241.54 Million 270.83 Million 573.9 Million
Total Debt 1.17 Billion 1.13 Billion 827.99 Million 727.7 Million 606.53 Million 690.64 Million
Net Debt -321.76 Million -518.78 Million -746.25 Million -745.43 Million -664.61 Million -509.92 Million

Balance Sheet Charts